Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $19.3000 (4.66%) ($18.3700 - $19.3000) on Mon. Jan. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.19% (three month average) | RSI | 47 | Latest Price | $19.3000(4.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.7% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.095% in a week (0% probabilities). VIXM(-34%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.095% (StdDev 4.19%) | Hourly BBV | 2.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $10.98(-43.11%) | Inflection Point | Yes | Resistance Level | $19.52 | 5 Day Moving Average | $18.65(3.49%) | 10 Day Moving Average | $18.91(2.06%) | 20 Day Moving Average | $19.52(-1.13%) | To recent high | -26.7% | To recent low | 52.2% | Market Cap | $1.434b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |